C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6)

European Journal of Pharmacology

Volumn 419, Issue 1, 2001, Pages 33-37

  Kotlińska, Jolanta ^a   Suder, Piotr ^b   Sciubisz, Agnieszka ^b   Legowska, Anna ^c   Eilmes, Julita ^b   Rolka, Krzysztof ^c   Silberring, Jerzy ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

Glycine; Metabolism; Opioid receptor; Orphanin FQ nociceptin; Pain

Indexed keywords

NOCICEPTIN; NOCICEPTIN DERIVATIVE; PHENYLALANYLGLYCYLGLYCYLPHENYLALANYLTHREONYLALANINE; PHENYLALANYLGLYCYLGLYCYLPHENYLALANYLTHREONYLGLYCINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; HOT PLATE TEST; HYPERALGESIA; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL REFLEX;

AMINO ACID SEQUENCE; ANIMALS; HYPERALGESIA; MALE; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 0342903137     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00955-4     Document Type: Article

References (27)

1. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL1 in the central nervous system of the rat. J. Comp. Neurol. 368:1996;229-251.
2. Chavkin C., Goldstein A. Specific receptor for the opioid peptide dynorphin; structure-activity relationships. Proc. Natl. Acad. Sci. U. S. A. 78:1981;6543-6547.
3. Fricker, L.D., Leiter, E.H., 1999. Peptides, enzymes and obesity: new insights from a "dead" enzyme. TIBS, 24, 390, 393.
4. Hara N., Ninami T., Okuda-Ashitaka E., Sugimoto T., Sakai M., Onaka M., Mori H., Imanishi T., Shingu K., Ho S. Characterization of nociceptin hyperalgesia and allodynia in concious mice. Br. J. Pharmacol. 121:1997;401-408.
5. Houtani T., Nishi M., Takeshima H., Nukada T., Tetsuo S. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719.
6. Julius D. Home for an orphan endorphin. Nature. 377:1995;476.
7. King M.A., Rossi G.C., Chang A.H., Williams L., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223:1997;113-116.
8. König J.F.R., Klippel R.A. The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of Brain Stem. 1963;1-157 Williams and Wilkins Co. Baltimore.
9. Kotlińska J., Suder P., Legowska A., Rolka A., Silberring K. Orphanin FQ/nociceptin inhibits morphine withdrawal. Life Sci. 66:2000;119-123.
10. Lapalu S., Moisand C., Mazarguil H., Cambois G., Mollereau C., Meunier J.-C. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides. FEBS Lett. 417:1997;333-336.
11. Mathis J.P., Goldberg I.E., Letchworth S.R., Ryan-Moro J.P., Pasternak G.W. Identification of high-affinity orphanin FQ/nociceptin(1-11) binding site in mouse brain. Synapse. 34:1999;181-186.
12. Maves T.J., Gebhart G.F. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in rats. Anesthesiology. 76:1992;91-99.
13. Meunier J.C., Mollereau C., Toll L., Suandeau C., Maisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
14. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
15. Montiel J.-L., Cornille F., Roques B., Noble F. Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem. 68:1997;354-361.
16. Okuda-Ashitaka E., Tachibana S., Houtani T., Minami T., Masu Y., Nishi M., Takeshima H., Sugimoto T., Ito S. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus. Mol. Brain Res. 43:1996;96-104.
17. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
18. Rossi G.C., Leventhal L., Bolan E., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282:1997;858-865.
19. Rossi G., Perlmutter M., Leventhal L., Talatti A., Pasternak G.W. Orphanin/nociceptin analgesia in the rat. Brain Res. 792:1998;327-330.
20. Saito Y., Maruyama K., Kawano H., Hagino-Yamagishi K., Kawamura K., Saido T.C., Kawashima S. Molecular cloning and characterization of a novel form of neuropeptide gene as a developmentally regulated molecule. J. Biol. Chem. 271:1996;15615-15622.
21. Sakurada T., Sakurada S., Katsuyama S., Sakurada C., Tan-No K., Terenius L. Nociceptin (1-7) antagonizes nociceptin-induced hyperalgesia in mice. Br. J. Pharmacol. 128:1999;941-944.
22. Sakurada T., Sakurada S., Katsuyama S., Hayashi T., Sakurada C., Tan-No K., Johansson H., Sandin J., Terenius L. Evidence that N-terminal fragments of nociceptin modulate nociception-induced scratching, biting and licking in mice. Neurosci. Lett. 279:2000;61-64.
23. Schulz S., Schreff M., Nüss D., Gramsch C., Höllt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. NeuroReport. 7:1996;3021-3025.
24. Smoluch M.T., Suder P., Kotlinska J., Sällberg M., Silberring J. Enzymatic degradation of nociceptin studied by LC-MS. Protein Pept. Lett. 6:1999;49-53.
25. Suder P., Kotlińska J., Smoluch M.T., Sällberg M., Silberring J. Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment. Peptides. 20:1999;239-247.
26. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport. 7:1996;2092-2094.
27. Yaksh T.L., Dirksen R., Harty G. Antinociceptive action of intrathecally administered cholinomimetics in rat and cat. Eur. J. Pharmacol. 117:1985;81-88.